Cinnarizine 25 mg (50 tablets) Inbiotech

sopharma shop

Product Filter

SKU: 10003929 Categories: ,
Sale!

Cinnarizine 25 mg (50 tablets) Inbiotech

Form

TABLETS

Content

50 tablets

Weight

0.05 kg

1,04

Secure Payments With

Cinnarizine of the pharmaceutical company Inbiotech is a medicinal product in the form of tablets used as a supportive treatment for symptoms of tinnitus, labyrinth disturbances, nystagmus, for the prevention and treatment of motion sickness, as well as for nausea and vomiting. Cinnarizine also reduces the excitability of the center of equilibrium, increases the resistance of cells to the lack of oxygen. It leads to the expansion of blood vessels, suppressing the processes of calcium transport through cell membranes. It has a mild sedative effect.

Available in a pack of 50 tablets.

Ingredients:

Cinnarizine 25 mg; lactose, wheat starch, povidone, silicon dioxide, talc and magnesium stearate.

 

Usage

The usual dose is:

– for vestibular disorders – 1 Cinnarizine tablet 3 times a day.
– in case of travel sickness – 1 tablet 30 minutes before travel and 1 tablet every 6 hours (for a long journey).

For children from 6 to 12 years: half of the adult dose. Maximum permissible daily dose:
– no more than 225 mg (9 tablets).

More Information

Unwanted reactions:

In compliance with the recommended dosages and duration of treatment, Cinnarizine is well tolerated and rarely causes minor and rapidly transient side effects. On the part of the CNS, dizziness, headache, feeling of fatigue can be observed. Mental disorders can manifest with depressive states, especially in elderly patients with emotional instability. With long-term use in high doses, movement disorders of a Parkinson-like type may occur in adult patients. In the event of neurological or mental disorders, it is necessary to immediately stop taking the drug and seek consultation with the attending physician. On the part of the gastrointestinal tract, nausea, vomiting, suppression of appetite, transient diarrhea, dry mouth, with prolonged treatment, increase in body weight are more often observed. These symptoms are prevented by reducing the dosage. In rare cases, hypersensitivity reactions are possible – itching, skin rashes. In extremely rare cases, symptoms resembling lupus erythematosus or lichen ruber planus may occur. In such cases, it is necessary to stop the treatment after consulting a doctor.

Cinnarizine Uniform is not used for:

– hypersensitivity to the medicinal substance or other inactive substances included in the composition of the preparation.

– patients with movement disorders such as Parkinson’s disease

– severe liver and kidney diseases.

Take special care when using Cinnarizine:

At the beginning of treatment, individual patients may experience more pronounced drowsiness. This effect of the drug can be enhanced by the simultaneous use of alcohol or drugs that depress the CNS. For this reason, Cinnarizine treatment of drivers and persons operating machinery should be considered carefully. During treatment with Cinnarizine, it is necessary to monitor blood pressure values, because in rare cases, in individual patients, the drug can cause a more significant decrease in blood pressure, especially at the beginning of treatment. If long-term treatment with the preparation is necessary, monitoring of the blood count and liver function is recommended. The composition of the preparation includes wheat starch as an auxiliary substance, which may pose a certain risk for people with celiac disease.

Administration of Cinnarizine and food and drink intake:

There is no evidence of the need for a special diet or restrictions on certain types of food and drink during treatment with Cinnarizine. Alcohol should not be consumed during treatment with the product.

Pregnancy and breast-feeding:

There are no data on the harmful effect of cinnarizine on the fetus. Nevertheless, its use in pregnant women, as with other drugs, should be done only after assessing the benefit/risk ratio for the mother and the fetus. There are no clinical observations on the excretion of cinnarizine in breast milk, therefore its use during breastfeeding is not recommended.

Driving and using machines:

At the beginning of treatment, Cinnarizine can cause a more pronounced sedative effect, which requires careful consideration of its use by drivers and persons working with machines. Important information about some of the ingredients of Cinnarizine The medicinal product contains wheat starch and may be dangerous for people with celiac disease.